Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taige Zhao

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
IEEE Transactions on Neural Networks and Learning Systems|April 7, 2023
Distributed Optimization of Graph Convolutional Network Using Subgraph VarianceTaige Zhao, Xiangyu Song, Man Li, et al.
Applied Psychology. Health and Well-Being|August 16, 2022
Changes of medical staffs' subjective well-being in China (2004-2020): A cross-temporal meta-analysisLiang Sheng, Taige Zhao, Jinxiao Liu, et al.
European Journal of Medicinal Chemistry|April 14, 2023
Discovery of bipyridine amide derivatives targeting pRXRα-PLK1 interaction for anticancer therapyJun Chen, Taige Zhao, Fengming He, et al.
Bioorganic Chemistry|February 12, 2020
Synthesis and biological evaluations of N'-substituted methylene-4-(quinoline-4-amino) benzoylhydrazides as potential anti-hepatoma agentsBaicun Li, Feifeng Zhu, Fengming He, et al.
Journal of Medicinal Chemistry|November 17, 2025
Structure-Based Design and Optimization of Bi-Aryl Amide Derivatives as Nur77 Ligands for Nur77-Bcl-2-Dependent Apoptotic Cancer TherapyTaige Zhao, Jun Chen, Wenbin Hong, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 26, 2023
Design, synthesis, and evaluation of novel benzoylhydrazone derivatives as Nur77 modulators with potent antitumor activity against hepatocellular carcinomaFengming He, Jun Chen, Taige Zhao, et al.
Acta Pharmaceutica Sinica. B|January 14, 2025
Discovery of a novel exceptionally potent and orally active Nur77 ligand NB1 with a distinct binding mode for cancer therapyJun Chen, Taige Zhao, Wenbin Hong, et al.
Bioorganic Chemistry|February 19, 2022
Discovery of a Nur77-mediated cytoplasmic vacuolation and paraptosis inducer (4-PQBH) for the treatment of hepatocellular carcinomaBaicun Li, Jiangang Huang, Jie Liu, et al.
British Journal of Cancer|October 26, 2023
The novel CDK9 inhibitor, XPW1, alone and in combination with BRD4 inhibitor JQ1, for the treatment of clear cell renal cell carcinomaZhijian Kuang, Kaiqiang Guo, Yin Cao, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
IEEE Transactions on Neural Networks and Learning Systems|April 7, 2023
Distributed Optimization of Graph Convolutional Network Using Subgraph VarianceTaige Zhao, Xiangyu Song, Man Li, et al.
Applied Psychology. Health and Well-Being|August 16, 2022
Changes of medical staffs' subjective well-being in China (2004-2020): A cross-temporal meta-analysisLiang Sheng, Taige Zhao, Jinxiao Liu, et al.
European Journal of Medicinal Chemistry|April 14, 2023
Discovery of bipyridine amide derivatives targeting pRXRα-PLK1 interaction for anticancer therapyJun Chen, Taige Zhao, Fengming He, et al.
Bioorganic Chemistry|February 12, 2020
Synthesis and biological evaluations of N'-substituted methylene-4-(quinoline-4-amino) benzoylhydrazides as potential anti-hepatoma agentsBaicun Li, Feifeng Zhu, Fengming He, et al.
Journal of Medicinal Chemistry|November 17, 2025
Structure-Based Design and Optimization of Bi-Aryl Amide Derivatives as Nur77 Ligands for Nur77-Bcl-2-Dependent Apoptotic Cancer TherapyTaige Zhao, Jun Chen, Wenbin Hong, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 26, 2023
Design, synthesis, and evaluation of novel benzoylhydrazone derivatives as Nur77 modulators with potent antitumor activity against hepatocellular carcinomaFengming He, Jun Chen, Taige Zhao, et al.
Acta Pharmaceutica Sinica. B|January 14, 2025
Discovery of a novel exceptionally potent and orally active Nur77 ligand NB1 with a distinct binding mode for cancer therapyJun Chen, Taige Zhao, Wenbin Hong, et al.
Bioorganic Chemistry|February 19, 2022
Discovery of a Nur77-mediated cytoplasmic vacuolation and paraptosis inducer (4-PQBH) for the treatment of hepatocellular carcinomaBaicun Li, Jiangang Huang, Jie Liu, et al.
British Journal of Cancer|October 26, 2023
The novel CDK9 inhibitor, XPW1, alone and in combination with BRD4 inhibitor JQ1, for the treatment of clear cell renal cell carcinomaZhijian Kuang, Kaiqiang Guo, Yin Cao, et al.
Pageof 1